Satisfaction is an important patient reported outcome of genetic counseling, as it is one of the elements used by professional organizations
INTRODUCTION
Well-known definitions of genetic counseling have been put forth by both the American Society of Human Genetics (1975) and the National Society of Genetic Counselors (NSGC, 1992) . At their essence, these definitions characterize genetic counseling as a specialty field focused on the assessment, interpretation, and communication of inherited risk information. In addition, the goals of genetic counseling have been clearly delineated in the Code of Ethics for Genetic Counselors (NSGC, 1992) . These goals include imparting medical information to patients, providing psychological support, and fostering autonomous and informed decision making.
Quality Improvement
Genetic counseling professionals strive to provide services to their patients that meet and exceed the aforementioned standards and expectations. As such, the significance of continuously monitoring and improving the quality of genetic counseling services (i.e., patient and clinical performance ratings) is a priority both from within the profession itself (Biesecker and Peters, 2001) , as well as from healthcare accrediting bodies. For example, the Joint Commission on Accreditation of Healthcare Organizations includes patient reported outcome data among those that hospitals and others must provide (Joint Commission Journal on Quality Improvement, 1995). Therefore, the ability to assess the quality of genetic counseling services in a reliable and valid manner is critical for the continuing advancement of the profession.
Fortunately, the ability to demonstrate the quality of genetic counseling is not a new concept in the realm of clinical genetics and genetic counseling (Biesecker and Peters, 2001; Lea, 1996) . For example, studies have examined specific outcome variables, including patient knowledge and information recall, changes in risk perception and anxiety, and screening behaviors (Michie et al., 1997; Nordin et al., 2002; Sagi et al., 1998; Stadler and Mulvihill, 1998) . These studies suggest that genetic counseling is effective at increasing patient knowledge while also helping to correct cancer risk misinterpretations and decrease levels of anxiety.
Patient Satisfaction
In addition to the patient reported outcomes mentioned above, other studies have looked directly at another area of healthcare quality-patient satisfaction (see Newsome and Wright, 1999 for review) . According to Haas (1999) , patient satisfaction with healthcare may be conceptualized as a comparison between what is expected and what is received. To Haas (1999) , this conceptualization stems from the rise of consumerism, and an increased emphasis on individual preference. Though some research has demonstrated a relationship between expectations and satisfaction, this relationship is complex and additional work in this area is needed (Haas, 1999) .
Functionally, patient satisfaction with healthcare is often measured through self-report using quantitative and qualitative methods that ask about patients' perceptions and their evaluations of the services they received (Haas, 1999; see also van Campen et al., 1995 for review) . As patient perceptions about healthcare interactions are highly malleable states (Dwyer, 2001) , it is reasonable to consider that patient satisfaction may vary from one healthcare encounter to the next, and be susceptible to change over time (Wensing and Elwyn, 2003) .
Patient Satisfaction With Genetic Counseling
The preponderance of the available data suggest that the majority of patients are highly satisfied with the counseling they have received (Bleiker et al., 1997; Nordin et al., 2002; Sagi et al., 1998; Schneider et al., 1999; Shiloh et al., 1990; Stadler and Mulvihill, 1998; Veach et al., 1999) . These studies also find that patients believe their counseling sessions are helpful and informative, as well as valuable in terms of expending limited time and financial resources.
Given the potential importance of patient satisfaction research for the ongoing improvement of the quality of genetic counseling services, several measures have been developed for this purpose, and many of them are available for review on the NSGC membership website.
5 These measures typically consist of quantitative (i.e., Likert and Guttman scaling), close-ended items (Lea, 1996; Shiloh et al., 1990) , as well as qualitative, open-ended items that allow patients a greater opportunity to provide more descriptive comments on their genetic counseling experience (Veach et al., 1999) . Most of these measures assess patient contentment with patientprovider rapport, amount of information provided, and time devoted to counseling. Recently, Skirton (2001) identified "need for certainty" as an additional element of patient satisfaction. However, none of the published measures (with the exception of the report by Shiloh et al., 1990) have been subjected to rigorous evaluation of their psychometric properties, which detracts from their utility. In addition, many of the measures are quite lengthy, which also limit their use in clinical setting.
In order to remediate some of these limitations, Tercyak et al. (2001) developed the Genetic Counseling Satisfaction Scale (GCSS). The GCSS consists of six items and was first used with patients seeking prenatal genetic counseling (Tercyak et al., 2001 ). This measure is concise, simple to administer, and addresses the broad goals of genetic counseling. As such, the GCSS is likely applicable to other types of genetic counseling, including cancer genetic counseling.
Cancer genetic counseling is typically conducted over the course of two sessions: a pretest session where information is gathered, and a disclosure session where test results are shared. Thus, pretest cancer genetic counseling is similar to prenatal genetic counseling as both sessions focus on patient decision making and occur in the absence of test result information. Assessing patient satisfaction at pretest allows for such information to be gathered independent of test outcome. This is important because both Shiloh et al. (1990) and Schneider et al. (1999) have found test result to influence satisfaction. However, as there are also fundamental differences between prenatal counseling and cancer genetic counseling (e.g., session intent, content, length), it is possible that these differences may affect the level of satisfaction reported by patients undergoing cancer genetic counseling.
In light of these issues, the goals of this study were to: (1) determine the reliability of the GCSS within a sample of women participating in pretest cancer genetic counseling; (2) describe women's satisfaction with pretest counseling for hereditary breast-ovarian cancer risk; (3) compare women's satisfaction to that of women participating in genetic counseling for prenatal diagnosis, and; (4) identify sociodemographic (age, race, marital status, education, income) and medical (cancer history) correlates of satisfaction.
METHODS
The Georgetown University Medical Center institutional review board reviewed and approved this protocol. After being informed about the study, participants were asked to read and sign a written informed consent form that explained the nature and purpose of the study, as well as its likely risks and benefits.
Subjects
From 1999 through 2001, the Lombardi Comprehensive Cancer Center's Cancer Assessment and Risk Evaluation (CARE) Program served as the source of participants in this study. At the time this investigation was conducted, the CARE Program was a no-cost, comprehensive, patient education and cancer genetic counseling, and BRCA1/2 testing research effort. To be eligible for this ancillary study that was primarily focused on maternal communication of BRCA1/2 test results to pediatric-age children, participants must have been English-speaking, mother to at least one child between the ages of 8 and 17 years, and must have provided a blood sample for BRCA1/2 mutation analysis. A total of 82 women were identified as eligible and the overall study consent rate was 89%. However, data analysis was limited to the subset of 61 (74%) participants who were administered and completed a genetic counseling satisfaction measure.
Procedures
All procedures are described in Tercyak et al. (2002) . Participants provided extensive sociodemographic, medical history, and psychological data via telephone and were then scheduled to attend an in-person pretest genetic counseling session with a genetic counselor or nurse educator. The pretest session included qualitative risk assessments based upon personal and family history, details about the process of testing for BRCA1/2 mutations and interpretation of test results, cancer risks associated with BRCA1/2 gene mutations, options for cancer prevention and surveillance, a discussion of the benefits and risks/limitations of testing, and information about the possible psychosocial impact of testing. Immediately following the pretest session and opportunity to provide a blood sample for BRCA1/2 mutation analysis, participants were asked by study personnel (principal investigator [K.P.T.] or research associate) to complete a genetic counseling satisfaction measure. This measure was entirely self-administered in private, and participants were informed that the ratings would be kept confidential and would not be shared with their genetic counselor. When test results became available, women were invited to an individual disclosure genetic counseling session which was scheduled at the participant's convenience.
Measures

Sociodemographics
Age, race, marital status, education level, and family income were assessed.
Medical
Personal history of cancer (Yes/No) was identified for each participant via self-report, and BRCA1/2 test results (positive, true negative, uninformative) were also obtained through participation in the CARE Program.
Satisfaction
Patient satisfaction with genetic counseling was assessed via the Genetic Counseling Satisfaction Scale (GCSS). The GCSS is a 6-item Likert scale that assesses participant satisfaction with the process and content of genetic counseling (see Appendix). The GCSS was developed and validated on a large sample of women participating in genetic counseling for prenatal diagnosis (Tercyak et al., 2001) ; it was found to be reliable (Cronbach's coefficient alpha = .80), face valid, and inversely related to women's anxiety levels.
RESULTS
Sample Characteristics
Demographic characteristics of the study sample are provided in Table I . The average age of participants was 45 years, and the majority was Caucasian, married or living as married, college graduates, and had an annual family income of $75,000 or more. Slightly more than one-half of participants had been affected by cancer in the past, and 59% ultimately went on to receive an indeterminate BRCA1/2 test result.
Reliability Analysis
The first goal of this study was to determine the reliability of the GCSS. In doing so, the study sought to answer the question of whether or not the GCSS yields consistent and reproducible measurements. Therefore, the first step in the data analysis plan was to examine the correlation of each GCSS item with the corrected total score. Following the recommendations of Nunally and Bernstein (1994) , any items with low corrected item-total correlations (<0.40) should be discarded. As shown in Table II , correlations ranged from 0.45 to 0.88 and all items were retained. The next step in the reliability analysis plan was to calculate the internal consistency reliability of the GCSS. This step is used to determine the homogeneity of the items, or if all of the items measure the same property. Typically, internal consistency reliability is determined by computing Cronbach's coefficient alpha (Nunally and Bernstein, 1994) . A result that meets or exceeds 0.70 is generally considered to be an indication that the measure is reliable. In this sample, the reliability of the GCSS was found to be 0.90, suggesting it has good psychometric properties. Also shown in Table II are the alphas if individual GCSS items were deleted, and this too suggests the GCSS has good psychometric properties.
Descriptive and Comparative Analyses
The second and third goals of this study were to describe the level of satisfaction evidenced by participants, and to compare their satisfaction to published normative scores obtained from women who participated in prenatal genetic counseling. As shown in Table II , mean GCSS item scores suggest that participants were highly satisfied with the care they received in all areas. The average GCSS total score was 26.87 (SD = 3.87) (item M = 4.48, minimum = 3.75, maximum = 4.69, range = 0.93). When compared to GCSS scores derived from a normative sample of women (M age = 35 years; 85% Caucasian) who had participated in prenatal genetic counseling (M = 27.70, SD = 3.10), satisfaction with cancer genetic counseling was statistically equivalent (Welch's t[105] = 1.36, p = .18), suggesting that there were no differences in satisfaction between the two types of counseling.
Bivariate Analyses
The final goal of this study was to determine which, if any, sociodemographic and medical characteristics were associated with satisfaction. The study's power to detect effects was at least 80% for bivariate associations in the low range. However, given the relatively homogenous nature of this sample, it was not possible to conduct bivariate analyses with the race, marital status, and education variables, as there were too few participants across nondominant categories. For the remaining categorical variables, Student's t tests were used to compare levels of satisfaction. Overall, there were no differences in satisfaction based on annual household income (t[59] = −1.20, p = .24) or cancer history (t[59] = −0.45, p = .66). With regard to age, the Pearson product-moment correlation was used to determine the strength of the association between age and satisfaction, which was determined to be near zero (r = .04, p = .76).
DISCUSSION
In order to provide empirical data within the realm of patient satisfaction with genetic counseling, a new standardized satisfaction measure, the GCSS, was introduced within a sample of women participating in pretest cancer genetic counseling. The measure was found to be reliable. As previously described in the literature, (Bleiker et al., 1997; Sagi et al., 1998; Stadler and Mulvihill, 1998) patients participating in cancer genetic counseling were highly satisfied with the level of care that they received in all areas. In addition, there was no difference in satisfaction between women participating in pretest cancer genetic counseling and those seen for prenatal counseling. This suggests that even though there are inherent differences between these two types of counseling, these differences are not reflected in overall patient satisfaction. Further, although counseling and testing were provided at no-cost for women evaluated for BRCA1/2 mutations, their level of satisfaction was equivalent to those seen in the fee for service prenatal setting. This suggests an intrinsic ability of genetic counseling to meet patient needs apart from its cost. With respect to sociodemographic characteristics, there were no differences in satisfaction based on age or annual household income. With respect to medical characteristics, there was no difference in satisfaction between those women affected with breast or ovarian cancer versus those who were unaffected with cancer.
At pretest (prior to when actual results are known), satisfaction appears to be somewhat uniformly high. In contrast, Shiloh et al. (1990) reported that a major factor involved in overall patient satisfaction is the type of information learned during genetic counseling. It is understandable that if a patient anticipates receiving or does receive "good news" (i.e., a true negative result) as opposed to "bad news" (i.e., a positive or indeterminate result), she may report more satisfaction with her genetic counseling experience. This may be based simply on the type of information learned, as opposed to the patient's actual experience. Schneider et al. (1999) has also examined the relationship between patient satisfaction and genetic test result, specifically with regard to the amount of time devoted to the patient during genetic counseling. The results of that study indicated that 93% of women with positive or indeterminate test results were highly satisfied with the amount of time spent with them during genetic counseling, while only 71% of women with a true negative test result were highly satisfied with the amount of time allotted. As the medical implications of a true negative test result are typically straightforward, genetic counselors may spend less time with these patients discussing the medical (and possibly also the psychological) impact of a true negative test result. According to Schneider et al. (1999) , this may leave these patients feeling "let down" by their genetic counseling providers who had previously been highly focused on their medical and emotional needs when it was believed that they were at increased risk for developing cancer.
The results of Schneider et al. (1999) and Shiloh et al. (1990) provide further evidence of the need to assess satisfaction in order to maintain and improve the quality of the genetic counseling experience for patients. By using a concise, simple to administer patient satisfaction measure that addresses the broad goals of genetic counseling (such as the GCSS), genetic counseling professionals can determine whether or not they have fulfilled the goals of genetic counseling. As suggested by DeMarco et al. (2001) , it is often necessary to tailor a genetic counseling session to address the specific needs of the different types of patients undergoing counseling for hereditary cancer risk. This may help professionals continue to improve upon the content and delivery of services.
Although there were no differences in satisfaction based on several characteristics in the present study and satisfaction was uniformly high, those practicing in the field should nevertheless recognize the potential importance of these factors and that it is impossible to fully satisfy all patients. Furthermore, genetic counseling professionals should not assume that if patients receive "good news" that they will necessarily be satisfied with their genetic counseling experience. Perhaps the most reasonable suggestion is that in order to help ensure that patients experience their genetic counseling as satisfying and valuable, counselors should strive to attend to the stress faced by their patients, do so out of genuine concern for patient well-being, and spend adequate time with patients to facilitate their understanding and informed decision making.
As stated, there are important clinical implications of this study; however, there are also limitations. The sample size was small, composed of a relatively homogenous group of women, and consisted of only women who were mothers to pediatric-age children. It is possible that this latter characteristic may have enhanced the professionals' provision of, or patients' receipt of, genetic counseling.
In addition, no-cost genetic counseling and testing were provided as part of a research study, which further limits the generalizability of the findings. Similarly, comparisons between the cancer genetic counseling and prenatal counseling participants should be interpreted cautiously as they were ascertained differently. Further, though the GCSS is a face-valid measure, other forms of validity were not assessed, nor did we assess the potential impact of qualitative or quantitative risk estimates on satisfaction. And finally, pretest genetic counseling satisfaction data could not be obtained on participants who declined to provide a blood sample for BRCA1/2 mutation analysis due to the study's eligibility criteria. As Wensing and Elwyn (2003) point out, this sampling may systematically exclude participants who are less satisfied. In general, replication and expansion of these results in larger and more diverse populations and settings is suggested.
Despite some limitations, the GCSS is likely a useful tool. Future research with the GCSS should be conducted to assess satisfaction and its relationship to other patient reported outcomes. Research with the GCSS could also be conducted to assess patient satisfaction with burgeoning technologies in genetic counseling service delivery, such as interactive educational CD-ROM programs and decisionaids (Green et al., 2001; Kaufman et al., 2003) , videotaped informational adjuncts (Cull et al., 1998) , telephone genetic counseling (Ormond et al., 2000) , and other telemedicine modalities (Gattas et al., 2001) . The GCSS could be used to compare the equivalency of patients' satisfaction with these novel approaches to the more traditional face-to-face format. This measure could also be used to evaluate satisfaction among diverse patient populations across a variety of settings. Such studies, combined with data about other outcomes of genetic counseling, could also be used as the basis for developing clinical protocols that are geared toward enhancing patient satisfaction. Collectively, the findings could help genetic counseling professionals design and implement programs that merge the goals of genetic counseling with the needs and expectations of patients. Ultimately, patients who are more satisfied with their genetic counseling experience may be better able to make more informed, quality decisions about genetic testing, with fewer adverse effects.
APPENDIX: GENETIC COUNSELING SATISFACTION SCALE (GCSS)
Instructions. In an effort to continuously monitor and improve the quality of genetic counseling services delivered to patients at this healthcare organization, please take a moment to fill-out this form regarding the appointment you just completed with your genetic counseling professional. Please read each statement below very carefully, and tell us how much you agree or disagree with each statement by circling your response on the scale to the right. Your honest responses will be kept strictly confidential, and they will not be shared with your genetic counseling professional. Thank you for assisting us. 
